A110 Efficacy of liposomal bupivacaine versus bupivacaine in port site injections on postoperative pain within enhanced recovery after bariatric surgery (ERABS) program; A Randomized Clinical Trial

Use of liposomal bupivacaine (Exparel®) in surgery is reported with decreased postoperative opioid requirements. The efficacy of liposomal bupivacaine versus standard bupivacaine injections at laparoscopic port sites during bariatric surgery is unknown.